Cell and Gene Therapy Technologies
The field of cell therapies has shown rapid growth in the industry over the past few years, driven by dramatic clinical results. With Cytiva’s strength in biomanufacturing, we are well positioned to enable progress in the industry by providing technologies and services to support the entire workflow.
We are seeking:
- Technologies, platforms (both hardware and software) as well as reagents and consumables relevant to the ex vivo cell therapy workflow
- Technologies for scaled manufacturing of viral vectors (AAV, LV, RV)
- Non-viral delivery technologies
- Analytics: Analytical tools applicable to both cell therapy and gene therapy manufacturing workflows (e.g. empty vs. filled particle analysis tools)
- Digital platforms for scheduling, logistics, and tracking of cell and gene therapies
- Opportunities to partner with large pharma in a broader collaboration model